Literature DB >> 12626208

The end of WISDOM.

Alastair MacLennan, David Sturdee.   

Abstract

Mesh：

Year:  2002        PMID： 12626208

Source DB:  PubMed          Journal:  Climacteric        ISSN： 1369-7137            Impact factor:   3.005


× No keyword cloud information.
  2 in total

1.  Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Authors:  Madge R Vickers; Alastair H MacLennan; Beverley Lawton; Deborah Ford; Jeannett Martin; Sarah K Meredith; Bianca L DeStavola; Sally Rose; Anthony Dowell; Helen C Wilkes; Janet H Darbyshire; Tom W Meade
Journal:  BMJ       Date:  2007-07-11

2.  Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM.

Authors:  Bronwen J Paine; Nigel P Stocks; Alastair H MacLennan
Journal:  Trials       Date:  2008-01-29       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.